Megan Baldwin

Megan Baldwin

Greater Melbourne Area
2K followers 500+ connections

Join to view profile
Opthea Limited

Über uns

Dr Megan Baldwin was appointed CEO and Managing Director of Opthea Limited (formerly Circadian Technologies), in February 2014. Dr Baldwin has over 20 years of experience focussing on angiogenesis and therapeutic strategies for cancer and ophthalmic indications. Dr Baldwin joined the company in 2008 and since then has held various positions, including Head of Preclinical R&D and Chief Executive Officer of Opthea Pty Ltd, which at that time operated as a 100% owned subsidiary of Circadian, developing OPT-302 (formerly VGX-300) for the treatment of wet age-related macular degeneration. Prior to Opthea, she was employed at Genentech (now Roche), the world leader in the field of angiogenesis-based therapies for cancer and other diseases. Her experience included several years as a researcher in the group of leading angiogenesis expert Napoleone Ferrara, before moving to Genentech’s commercial division and having responsibility for corporate competitive intelligence activities. In these roles, she developed extensive commercial and scientific knowledge in the field of anti-angiogenic and oncology drug development. She holds a PhD in Medicine from the University of Melbourne, having conducted her doctoral studies at the Ludwig Institute for Cancer Research and is a member of the Australian Institute for Company Directors and a board member of Ausbiotech.

Activity

Join now to see all activity

Erleben Sie

  • Opthea Limited

    Melbourne, Victoria, Australia

  • -

    Melbourne, Australia

  • -

    South Yarra

  • -

    Melbourne, Australia

  • -

  • -

  • -

  • -

    South San Francisco

  • -

    Melbourne

  • -

Bildung

  • Graphic

    -

  • -

    Characterisation of VEGF-D.

Volunteer Experience

  • Volunteer

    Monash Medical Centre

    - Present 28 years

Honors & Awards

  • Emerging Woman in Leadership Award

    BioMelbourne Network

Languages

  • Englisch

    Native or bilingual proficiency

Organizations

  • Ausbiotech

    Board Member

    - Present

    The Ausbiotech Board of Directors are elected as representatives of AusBiotech to provide strategic guidance and corporate management-related policies. Each Board member brings extensive experience of working in the Australian biotechnology industry, representing technical, commercial and policy expertise.

  • Veski

    Member Veski Connection

    - Present

More activity by Megan

View Megan’s full profile

  • See who you know in common
  • Get introduced
  • Contact Megan directly
Join to view full profile

Other similar profiles

Gemeinsame Artikel erkunden

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Megan Baldwin in Australia

7 others named Megan Baldwin in Australia are on LinkedIn

See others named Megan Baldwin

Add new skills with these courses

See all courses